MTOR and type 2 diabetes mellitus: In the T2DM group, there was a significant inhibition of AMPK (Figure 5E,F) and an augmentation of mTOR (Figure 5E,G) activity and TIMP-1 expression (Figure 5H) compared with the control animals.